AZ-Air - website for respiratory experts
  










Please enter your user name and
password.

User name:

Password:





Forgot your
password?


Do not have a password?






FAQ

 Contact us

Legal notice




International website for respiratory experts


Terbutaline delivered via Nebuhaler resulted in clinical improvement in respiratory parameters in pre-school and school-aged children.
 
1.  Pool JB, et al. Arch Dis Child 1988; 63: 288–91 





1. Pool JB, et al. Arch Dis Child 1988; 63: 288–91
 
Two groups of children, aged 5–7 and 2–5 years, were examined in this study. Terbutaline 500 µg delivered via Nebuhaler resulted in significant (p < 0.01) improvement in functional residual capacity (FRC) and PEF in the older group. The younger group was unable to perform accurate PEF testing, however, significant (p < 0.01) clinical improvement in FRC was observed. Each child’s results are shown by linked data points.

Terbutaline via Nebuhaler improves functional residual capacity and PEF in children aged 5-7 years

Each child's results are shown by linked data points.
Adapted from Pool et al., 1988.

 
back to top
 

Assists in the effective use of AstraZeneca’s pMDIs by patients who have problems co-ordinating actuation of the inhaler with inhalation 
Suitable for adults and children 
Provides greater lung deposition of drug than pMDI alone 
Reduces oropharyngeal drug deposition 
Effective delivery of inhaled budesonide to pre-school children with asthma 
Effective delivery of inhaled terbutaline to pre-school and school-aged children 
 
Alternative names for Nebuhaler 
Bibliography